充実した登録によるランダム化離脱臨床試験におけるフルアゴニストオピオイドに対する反応の予測要因:参加者レベルのデータメタ解析
Andrew Conroy1, Warren B Bilker1, Ian DeLorey1
1Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States.
Pain
|September 2, 2025
まとめ
慢性疼痛治療の成功を 完全アゴニストオピオイドで予測するのは困難です この研究では,強い予測要因は見つかりませんでしたが,臨床的判断と患者の厳密なモニタリングは,効果的な疼痛管理に不可欠であることを示しています.
科学分野:
- 薬理学について
- 痛みの管理
- 臨床試験
背景:
- 慢性疼痛にはフルアゴニストオピオイドが使用されます.
- 治療の成功を予測することは 患者のケアに不可欠です
- オピオイド治療を最適化することができます.
研究 の 目的:
- 慢性疼痛患者における成功の予測要因を特定するために,フルアゴニストオピオイドで治療.
- ランダム化離脱臨床試験の患者データを分析する.
- オピオイドの定位と維持段階の両方の予測要因を評価する.
主な方法:
- 5594人の患者から得られたデータを分析した.
- 9つの臨床試験のデータを活用した.
- 混合効果のロジスティック回帰と一般化された線形混合モデルを使用した.
主要な成果:
- 定量化が失敗した患者とフルアゴニストを継続した患者との間では,臨床的に重要な差異は認められなかった.
- 初期の痛みのスコアが高くなったのは 悪い結果を予測する 控えめな指標でした
- 患者からの報告では,治療への反応を予測できませんでした.
結論:
- オピオイド治療の成功に対する臨床的に有用な予測モデルは特定されなかった.
- 慢性的な痛みに対して オピオイドを使用するという決定は 慎重に臨床的判断が必要です
- 強い予測要因が欠如しているため,患者の厳密なモニタリングは不可欠です.
関連する概念動画
Opioid Analgesics: Synthetic and Semisynthetic Opioids
421
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
421
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Dose-Response Relationship: Overview
3.7K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.7K


